Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Trump backs down on Greenland tariffs, says deal framework reached
Death toll in Karachi mall fire climbs to around 50, official says
Rescuers search for survivors after landslide at New Zealand campsite
Israeli fire kills 11 Palestinians, including journalists and children
Trump says US will not use force to acquire Greenland
